Iterative Scopes logo

Iterative Scopes

Our Exclusive Partner for Artificial Intelligence

Artificial intelligence (AI) is fueling the future of healthcare technology and Provation’s solutions. Together, Provation and Iterative Scopes are empowering clinicians, life science researchers, and other healthcare leaders with the tools needed to work smarter, faster, and with more accuracy. After all, the quality of patient care depends on it.​

We’re on a mission to minimize disparities in healthcare with the help of Iterative Scopes’ scalable AI technology.​

Provation is proud to partner with Iterative Scopes, pioneers in the application of artificial intelligence-based precision medicine to gastroenterology. Together we’re driven to establish a new standard of care for the detection, and ultimately, treatment of gastrointestinal (GI) diseases. Our collective goal is to improve the speed, accuracy, and consistency of endoscopy readings, clinical trial recruitment, and procedure documentation – and we are doing so by integrating powerful, proprietary AI and computer vision technologies into our key solutions, like Provation® Apex.​

Iterative Scopes - Artificial Intelligence

Optimized patient recruitment ​ for IBD clinical trials – made possible with artificial intelligence

Whether you are running IBD clinical trials today, or new to clinical trials altogether, we can help relieve much of the patient recruitment burden for you.

Iterative Scopes AI Technology

AI Patient Recruitment

AI Patient Recruitment

Help accelerate the development of new therapies for your inflammatory bowel disease (IBD) patients with AI patient recruitment. This new service is designed to help clinicians, healthcare organizations, and pharmaceutical companies more efficiently and accurately identify prospective clinical trial candidates for IBD trials.​


AI Procedure Documentation

Provation is always seeking to further minimize the burden of physician documentation for endoscopic procedures. That’s why we’ve partnered with Iterative Scopes to develop an AI documentation integration that will enable direct scope to text interpretation – coming soon to Provation® Apex.

Latest News & Studies

Sept. 22, 2022

Iterative Scopes Receives FDA Clearance for AI-Assisted Polyp Detection Device SKOUT™

April 14, 2022

Enhancing the Standard of Care in Gastroenterology: Artificial Intelligence Applications

Feb. 22, 2022

Can an AI-driven data sharing effort advance IBD treatments? (Drug Discovery World)

Connecting you with the top talent in healthcare and AI ​

solve the puzzle

Massachusetts-based Iterative Scopes spun out of MIT in 2017 by founder and CEO, Jonathan Ng, MBBS. Now, Iterative Scopes is making waves throughout gastroenterology with significant achievements, including:

  • A network of partnerships with leading cross-industry GI stakeholders​
  • Top talent on its leadership team and scientific and industry advisory boards​
  • The backing of top tier financial institutions​
  • $150 million Series B financing round in December 2021​
  • $195 million + in investor funding since 2021​

​And we’re just getting started.​

Scroll to Top